Therefore, miR-424 has been proposed as a tumor suppressor acting via down-regulation of BCR-ABL and its up-regulation may have a therapeutic effect in chronic myeloid leukemia [63]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.